P2RX7 and Hyperglycemia: (47) has demonstrated that dihydromyricetin mitigates the deleterious effects of hyperglycemia on astrocytes and decreases the expression of inflammatory cytokines such as TNF-α and IL-1β by targeting the purinergic receptor P2X7.